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Abstract Astrocytes (AC) induce blood-brain barrier (BBB)
properties in brain endothelial cells (EC). As antioxidative
activity (AOA) is assumed to be a BBB characteristic, we tested
whether AC improve AOA of EC. Monocultivated AC showed
higher AOA [manganese superoxide dismutase (SOD), catalase
(Cat), glutathione peroxidase (GPx)] than EC. Cocultivation
elevated AOA in EC (MnSOD, CuZnSOD, Cat, GPx), and AC
(MnSOD, CuZnSOD, GPx). Hypoxia increased radical-
induced membrane lipid peroxidation in monocultivated, but
not in cocultivated EC. Thus, EC/AC cocultivation intensifies
AOA in both cell types, protects the EC, and therefore, the BBB
against oxidative stress. The high AOA is regarded as an
essential property of the BBB, which is induced by AC.
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1. Introduction
Brain microvascular endothelial cells (EC) form the blood-
brain barrier. Astrocytes (AC) ensheath vascular cylinders and
induce blood-brain barrier properties in EC, such as tight
junctions [1]. Reactive oxygen species, i.e. O32 ,
OH, H2O2,
ONOO3, cause lipid peroxidation [2] resulting in membrane
disturbances [3,4] and can open the blood-brain barrier [5,6].
Reactive oxygen species are continuously generated in the
vascular system [7] and in EC [5], which is intensi¢ed during
cerebral ischemia/reperfusion [5] or Alzheimer’s disease [8,9].
Therefore, high activities of antioxidatively acting enzymes in
brain microvessels have to be considered an essential property
of the blood-brain barrier [5]. Cytosolic copper-zinc and mi-
tochondrial manganese superoxide dismutases (SOD; EC
1.15.1.1) remove O32 . Catalase (Cat; EC 1.11.1.6) decom-
poses H2O2. Glutathione peroxidase (GPx; EC 1.11.1.9) elim-
inates lipid peroxides and H2O2 by oxidizing glutathione. Be-
cause of a relatively high antioxidative capability [10] AC can
protect neurons from oxidative stress [11]. However, the in-
£uence of AC on the antioxidative potential of EC has not
been thoroughly examined yet. During hypoxia/reoxygena-
tion, the tightness of the EC monolayer is preserved longer
in coculture with AC than in an EC monolayer in monocul-
ture which becomes leaky earlier [1].
Because reactive oxygen species increase the permeability of
the EC monolayer, protection of EC by a higher antioxidant
capacity of AC is assumed. Therefore, this study compares the
antioxidative activity of EC and AC. Since AC can induce
blood-brain barrier properties in EC, an increase in the anti-
oxidative potential of EC by cocultivation with AC is hy-
pothesized. To test this hypothesis, the activities of enzymes
involved in the defence of reactive oxygen species and radical-
induced lipid peroxidation were studied in monocultivated
and cocultivated EC and AC. Moreover, the in£uence of hy-
poxia/reoxygenation accompanied by the release of reactive
oxygen species on the radical-induced peroxidation of mem-
brane phospholipid was investigated.
2. Materials and methods
2.1. Preparation and cultivation of cells
Cloned immortalized rat brain endothelial cells (RBE4, passage 43^
55, kindly supplied by Prof. Couraud, Paris, France), primary EC and
AC from Wistar rats were grown according to [6] in 95% air/5% CO2.
Monocultures of EC were cultivated on 6-well plates (Falcon) coated
with rat tail collagen I (Sigma). In coculture, EC were cultivated on
¢lter inserts (0.45 Wm pore size, 1.6U106 pores/cm2, Falcon, coated
with rat tail collagen I). AC were seeded on the bottom of 6-well
plates containing the ¢lters. Growth factor was omitted in the culture
medium of EC. EC expressed angiotensin converting enzyme, factor
VIII, alkaline phosphatase and Q-glutamyltranspeptidase, which were
intensi¢ed by cocultivation.
2.2. Hypoxia/reoxygenation
Con£uent monolayers were washed with phosphate bu¡ered solu-
tion (with Ca2, Mg2, glucose-free, pH 7.2; Biochrom). 1 ml/well
phosphate bu¡ered solution saturated with Nelson gas (95% N2/5%
CO2) was added and gassed with Nelson gas for 2 h at 37‡C resulting
in 3% O2 in the incubation solution (hypoxia). During reoxygenation,
cells were gassed with Carbogen (95% O2/5% CO2) for 0.5 h (for
enzyme detection) or 1 h (for malondialdehyde). Cells placed in an
incubator served as control [12].
2.3. Biochemical measurements, viability and statistical analysis
Cells were scraped o¡ in ice-cold H2O (Cat, SOD, GPx, malondial-
dehyde) or in 5% sulfosalicylic acid (glutathione) and homogenized
(except malondialdehyde samples) by sonication on ice (3U5 s with
breaks of 10 s). Activity of Cat was estimated according to [13] and
expressed as k in mg31 min31 (¢rst-order rate constant of the reac-
tion). Glutathione content was determined according to [14] ; reduced
(GSH) and oxidized (GSSG) glutathione were measured separately in
the absence (total glutathione) or after addition of 2-vinylpyridine (for
GSSG), using calibration standards. Activities of GPx and SOD were
determined using test kits (Randox, RS 506 and SD 125). GPx activity
was measured at 37‡C as reduction of cumene hydroperoxide (coupled
enzymatic assay with glutathione reductase) resulting in NADPH
oxidation, which was followed at 340 nm. Activity was calculated in
U g31. For SOD measurement, xanthine and xanthine oxidase were
used generating superoxide radicals which react with 2-[4-iodophenyl]-
3-[4-nitrophenol]-5-phenyltetrazolium chloride to form a red dye
(505 nm). The activity was calculated as the degree of inhibition of
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this reaction at 37‡C, using a standard curve for calibration. Activity
was expressed as U mg31. MnSOD was determined after addition of
1 mM KCN inhibiting CuZnSOD speci¢cally. Content of malondial-
dehyde was ascertained according to [15,16] using HPLC (Shimadzu
LC-10A chromatograph with a RF-10A £uorescence detector) and
malondialdehyde bis-[diethylacetal] (Merck) as standard. Under con-
trol culture conditions, malondialdehyde content was 0.18 þ 0.04 nmol
mg31 in RBE4 and 0.63 þ 0.09 nmol mg31 in AC. Protein was deter-
mined by the Lowry method (test kit, Sigma). Cell viability was de-
tected using the neutral red assay (50 Wg ml31 cultivation medium,
containing 2% FBS, 2 h at 37‡C). After washing, the absorbed dye
was extracted (50% ethanol/1% glacial acetic acid), and measured
(540 nm) [16]. Data represent mean þ S.D. Signi¢cance values were
calculated by Mann-Whitney rank sum test or Kruskal-Wallis one
way ANOVA on ranks followed by Student-Newman-Keuls test.
3. Results
The cell clone RBE4 expressed an antioxidative defence
similar to primary EC. Activities of Cat, GPx, content of
GSH and GSSG did not di¡er signi¢cantly between primary
EC (2.6 þ 0.8 min31 mg31, 28 þ 16 U g31, 89 þ 21 nmol mg31,
1.9 þ 2.6 nmol mg31 ; n = 5^8) and RBE4 (2.7 þ 0.2 min31
mg31, 27 þ 9 U g31, 76 þ 10 nmol mg31, 0.35 þ 0.2 nmol
mg31 ; n = 6^10). RBE4 possessed su⁄cient SOD activity
(3.2 þ 0.2 U mg31, n = 10) compared to primary EC
(1.9 þ 0.6 U mg31, n = 6; P6 0.001). Thus, RBE4 are suitable
for studying antioxidative defence in brain endothelial cells
and were used for all other experiments.
In monoculture, AC showed a higher antioxidative poten-
tial than EC (Fig. 1). In AC, the activities of MnSOD, Cat
and GPx were 229 þ 68%, 164 þ 40% and 449 þ 89%, respec-
tively, compared to those in EC (P6 0.003). GSSG was below
the detection limit in AC but detectable in EC. CuZnSOD
activity and GSH content did not di¡er signi¢cantly between
EC and AC. In coculture, EC and AC expressed signi¢cantly
higher activities compared to the respective monoculture ex-
cept Cat in AC, which was not signi¢cantly changed (Fig. 1).
Activity of CuZnSOD was only slightly elevated in EC after
cocultivation compared to the monocultivation (to
128 þ 10%). The activities of CuZnSOD and GPx in AC
were 203 þ 9% and 231 þ 22%, respectively, the activities of
Cat and GPx in EC were 219 þ 90% and 199 þ 40%, compared
to the respective monoculture. The activity of MnSOD in-
creased in AC to 698 þ 193%, in EC to 993 þ 196%. The con-
tent of GSH decreased in both EC and AC, but the di¡erence
was signi¢cant in EC only. GSSG was detectable neither in
EC nor in AC when cocultivated.
During hypoxia and reoxygenation, the total antioxidative
capability did not change substantially (n = 8, if not stated
otherwise; vs. the respective control). In monocultivated EC,
activities of Cat, GPx and CuZnSOD decreased after hypoxia
(to 78 þ 19%, 73 þ 15%, 78 þ 10%; P6 0.05 for GPx, CuZn-
SOD), whereas MnSOD activity was elevated to 122 þ 21%
(P6 0.05). After reoxygenation, activities of Cat, CuZnSOD
and MnSOD exhibited control levels, GPx di¡ered from the
control (88 þ 13%; P6 0.05). Monocultivated AC were less
sensitive to hypoxia than EC: only Cat activity declined (to
79 þ 9%; P6 0.05), GPx (n = 4) and CuZnSOD (n = 6) re-
mained unchanged. MnSOD activity increased to 185 þ 63%
(P6 0.05). During reoxygenation of AC, Cat activity re-
mained diminished (80 þ 9%; P6 0.05), GPx remained un-
changed, whereas CuZnSOD fell to 85 þ 4% (P6 0.05).
MnSOD activity tended to return to control level
Fig. 1. Activity of CuZnSOD, MnSOD, Cat, GPx and content of GSH, GSSG in brain EC and AC, in monoculture and in coculture (ECc,
ACc). Mean þ S.D.; CuZnSOD/MnSOD/GSH/GPx, n = 10; Cat/GSSG, n = 6. ***P6 0.001, **P6 0.01 in comparison to EC; ###P6 0.001 in
comparison to AC; ‘nd’ means not detectable (detection limit for glutathione 0.02 nmol mg31).
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(121 þ 33%; P6 0.05). Cocultivated EC were less sensitive
than monocultivated EC: all enzyme activities did not di¡er
signi¢cantly from the control during hypoxia and reoxygena-
tion, except CuZnSOD, which dropped to 92 þ 3% after reox-
ygenation (P6 0.05). In cocultivated AC, activities of Cat and
GPx did not change during hypoxia, SOD activities decreased
slightly (CuZnSOD to 90 þ 6%, MnSOD to 79 þ 10%;
P6 0.05). After reoxygenation, the activities of Cat, CuZn-
SOD and MnSOD were diminished to 62 þ 13%, 92 þ 5%
and 70 þ 15%, respectively (P6 0.05), GPx remained un-
changed.
Fig. 2 shows that the content of malondialdehyde increased
to 218 þ 82% in EC monocultures, and to 135 þ 10% in AC
monocultures after hypoxia and reoxygenation, compared to
the respective control (P6 0.01 each). If cells were coculti-
vated, hypoxia/reoxygenation only resulted in a slight, but
not signi¢cant increase in the content of malondialdehyde in
EC (to 121 þ 14%), and AC (to 118 þ 7%), compared with the
respective controls. In the case of EC, the cocultivation with
AC dramatically reduced the accumulation of malondialde-
hyde by about 100% (P6 0.05). Simultaneously, the survival
rate of EC, after hypoxia/reoxygenation, was improved by
cocultivation (99% viability), in comparison with that of EC
monoculture (79%).
4. Discussion
Comparing EC and AC in monoculture, it may be con-
cluded that AC possess a higher antioxidative potential than
EC, due to elevated activities of MnSOD, Cat and GPx, de-
composing reactive oxygen species, and lipid peroxidation in-
termediates. Moreover, no GSSG is detectable in AC, whereas
in EC a small amount of GSSG, an indicator of oxidative
processes, is found. This shows less oxidative load in AC
than in EC, under control conditions.
During hypoxia, AC exhibit less of a decrease in the activity
of the defence enzymes than EC. These data are in accordance
with other data which show decreased activities of antioxida-
tively acting enzymes in EC during hypoxia [17,18]. They also
show high resistance of AC to hypoxic stress, and only de-
creased MnSOD in AC after hypoxia [10]. Corresponding to
the lower antioxidative defence potential, monocultivated EC
exhibit a three times higher enhancement of radical-induced
peroxidation products of membrane phospholipids (by 118%)
than monocultivated AC (by 35%), upon hypoxia. Therefore,
it is assumed that the higher activities of antioxidatively acting
enzymes in AC may protect these cells better against hypoxic
events than those in EC. In addition, it can be expected that
the higher antioxidative potential of AC, covering the cerebral
surface of EC in vivo, prevents EC injury by reactive oxygen
species when liberated from the brain [5] during pathological
situations with oxidative stress, such as ischemia/reperfusion
or in£ammation.
Malondialdehyde (MDA) formation is taken as an indica-
tor of radical-induced cell injury in this study. Enhanced gen-
eration of MDA during hypoxia and reoxygenation has also
been observed in earlier studies of endothelial cells, using the
same experimental conditions [12,16]. The MDA accumula-
tion in EC occurs simultaneously with anaerobic glycolysis,
energy depression, loss of cytosolic enzymes, cell membrane
leakage, membrane disruption, and cell death [12]. During
hypoxia/reoxygenation, the MDA production is accompanied
by a rise in the content of 4-hydroxynonenal, which is pre-
vented by radical scavengers [16]. 4-Hydroxynonenal repre-
sents lipid peroxidation processes only induced by reactive
oxygen species (ROS) [19]. Thus, the assumption is supported
that ROS are liberated in the EC during hypoxia/reoxygena-
tion. This explains why, after hypoxia, higher lipid peroxida-
tion is found in EC monocultures, containing relatively low
activities of ROS-decomposing enzymes, than in AC, contain-
ing a signi¢cantly higher ROS-decomposing potential. The
relevance of ROS and ROS-mediated membrane lipid perox-
idation in causing hypoxia-related disturbances in EC is con-
¢rmed by pharmacological interventions with Cat and SOD.
The administration of SOD prevented both the MDA forma-
tion and the paraendothelial permeability increase caused in
EC cultures by hypoxia/reoxygenation [6]. Also, the addition
of Cat may protect the tightness of a macrovascular endothe-
lial cell monolayer during oxidative stress [20].
Cocultivation of EC and AC enhances the activities of anti-
Fig. 2. Changes of malondialdehyde (MDA) content in brain EC and AC after 2 h hypoxia followed by 1 h reoxygenation (h/r) in comparison
to control (co). Mean þ SD; n = 6 in each group. **P6 0.01 in comparison to the respective control, monoculture; #P6 0.05 in comparison to
the respective control, coculture.
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oxidatively acting enzymes, especially that of MnSOD, in
both cell types. The coculture system which is used avoids
morphological contacts between EC and AC. Therefore, solu-
ble factors have to mediate the increase in enzyme activities in
coculture, compared to the respective monocultures. For in-
stance, growth factors such as vascular endothelial growth
factor, acidic and basic ¢broblast growth factor (bFGF) im-
prove the resistance to oxidative stress in EC [21]. Cytokines,
such as tumor necrosis factor-K (TNFK), or interleukin-1 (IL-
1), induce MnSOD speci¢cally among antioxidatively acting
enzymes in di¡erent cell types [22], and induce protection
against cerebral ischemia [23,24]. AC and EC can produce
TNFK, IL-1, and bFGF [25], which can be intensi¢ed by
hypoxic events including ischemia/reperfusion [26]. Thus, it
may be assumed that the release of growth hormones and
cytokines causes the increase in the antioxidative potential
in cocultivated AC and EC. The improvement of the antiox-
idative enzyme capacity in EC by cocultivation is in accord-
ance with studies of the paraendothelial permeability, a func-
tional measure for the tightness of the blood-brain barrier
(BBB) formed by EC. These investigations show that the per-
meability is reduced (and the tightness improved) in EC after
coculture with AC, compared to EC monoculture [27]. The
expression of BBB markers, such as Q-glutamyltranspeptidase
or alkaline phosphatase, is also intensi¢ed in EC cocultivated
with AC, compared to EC monocultures [28]. Altogether, it is
concluded that AC improve BBB properties and the antiox-
idative potential of EC. The latter would simultaneously pro-
tect structures and functions of EC, and hence of the BBB,
against pathological situations with oxidative damage.
As a consequence of the cocultivation, MDA formation and
cell death, induced by hypoxia/reoxygenation, are substan-
tially reduced in cocultivated EC, compared to monoculti-
vated EC. That means these EC contain appreciable amounts
of antioxidants to protect against oxidative damage, as pre-
dicted earlier for the BBB [29]. However, the protective e¡ect
of cocultivation is probably not only due to the enhanced
activity of defence enzymes in EC, but also to the enhanced
defence potential in the AC, decomposing reactive species
released from EC. The tolerance of lipid peroxidation and
viability during hypoxia is in agreement with functional stud-
ies. These show that the paracellular permeability of EC cul-
tivated in contact with AC is enhanced only after 2 h of
hypoxia [28] ; in contrast, EC, in AC-conditioned medium
(no AC-EC contact), show the same permeability increase al-
ready after 1 h hypoxia [6]. Similar, AC-dependent di¡erences
in the resistance against hypoxia/reoxygenation have been re-
ported by [1], who found a protection of the paracellular
tightness of EC, cocultivated with AC, in contrast to EC
monocultures.
For the ¢rst time our data show a supporting e¡ect of AC
on EC, with regard to the antioxidative potential. This is
similar to what was reported for AC, which can protect neu-
rons from oxidative stress [11]. AC possess a higher antiox-
idative potential than EC and, in addition, AC enhance the
activities of antioxidatively acting enzymes in EC. Therefore,
cocultivation of EC with AC is expected, at least in part, to
maintain the tightness of the EC monolayer during oxidative
stress, by enhancement of the antioxidative capacity. In sum-
mary, AC induce the antioxidative potential in EC, forming
the blood-brain barrier, and hence, EC together with AC form
a barrier against radicals, which can be generated in both the
vascular system [7] and the brain [5]. Thus, the antioxidative
potential of EC in interaction with AC can be regarded as a
further essential property of the blood-brain barrier, which is
induced by AC.
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